Login to Your Account



CEO Role Models

In Biotech's New Normal, Skills at CEO Level Evolve

By Trista Morrison


Monday, August 15, 2011
The last four years have brought significant CEO turnover in the drug industry. Almost every big pharma has felt the churn, including Pfizer Inc., GlaxoSmithKline plc, Merck & Co. Inc., Roche AG, Sanofi SA, Eli Lilly and Co., Daiichi Sankyo Co. Ltd. and Astellas Pharma Inc., to name a few.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription